Blood and infection

Cancer-associated thrombosis: past, present, and future

February 2020 | By Jecko Thachil

Anticoagulant medications have dramatically decreased the morbidity and mortality associated with venous thromboembolism (VTE). Many episodes of VTE are unprovoked; when searching for the cause […]

Generic HIV treatments permit cost savings, but their implementation can be complex

February 2020 | By Martin Bradley

National spending on specialised services for the treatment of HIV is significant; in 2016/17, it was close to £540 million, of which antiretroviral treatment (ART) […]

A gloved hand holding a petri dish containing an aspergillus fungal colony

The new Commissioning for Quality and Innovation indicator on antifungal stewardship

November 2019 | By Martin Bradley

Antimicrobial stewardship is a healthcare system-wide approach to promoting and monitoring the judicious use of antimicrobials, such as antifungals, to preserve their future effectiveness.1 Such […]

Screens showing imaging of patent foramen ovale closure ongoing

NHS England confirms summer specialised funding decisions

October 2019

NHS England has published its decisions on which specialised treatments will be funded for routine commissioning based on recommendations from the May 2019 Clinical Priorities Advisory […]

Number of places available for HIV PrEP impact trial increased

May 2019

In January 2019, the research team running the the pre-exposure prophylaxis (PrEP) impact trial recommended making more places available. In April 2019, the PrEP Oversight […]

IVIg: new commissioning criteria and sub-regional panels

May 2019 | By Martin Bradley

As this journal has previously highlighted, continuity of intravenous immunoglobulin (IVIg) supply is a long-standing issue for the NHS. There have been several significant supply […]

Articles